| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.5 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.11 | 0.5 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |